SANTOSH PILLAI: Open Payments
NPI 1346405024 · HAGERSTOWN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,339 in 71 payments from 19 companies in 2025. Trend: 2023 $2,119 · 2024 $18,868 · 2025 $1,339
Food & beverage: $1,339
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $263 |
| Corium, LLC | 7 | $158 |
| Vanda Pharmaceuticals Inc. | 7 | $152 |
| Supernus Pharmaceuticals, Inc. | 6 | $107 |
| Teva Pharmaceuticals USA, Inc. | 6 | $104 |
| Axsome Therapeutics, Inc. | 5 | $103 |
| Lundbeck LLC | 4 | $89 |
| Alkermes, Inc. | 5 | $89 |
| Bausch Health US, LLC | 2 | $40 |
| Tris Pharma Inc | 2 | $39 |
Products named: CAPLYTA, Azstarys, FANAPT, REXULTI, Qelbree, AUSTEDO XR, Auvelity, ARISTADA.
Industry payments across MD — which companies pay providers there.
